
DeltaV Systems and Software for Life Sciences
Process automation, control, and data management for life sciences manufacturing with real-time quality monitoring and regulatory compliance.
Overview
DeltaV Systems and Software for Life Sciences is Emerson's unified automation platform and software suite purpose-built for life sciences manufacturers. Designed to accelerate therapy development, ensure regulatory compliance, and drive digital transformation, the platform serves organizations across primary manufacturing, secondary manufacturing, cell and gene therapy, and utilities operations. By combining flexible control systems with advanced manufacturing software, DeltaV helps life sciences facilities improve data management, real-time product quality, reliability, and operating costs throughout the entire product lifecycle.
The DeltaV Automation Platform supports manufacturers at every stage — from process development and tech transfer through commercial manufacturing and ongoing optimization. Emerson's technology, consultants, and global expertise help facilities advance along BioPhorum's Digital Plant Maturity Model, enabling cost-effective compliance, repeatable production, and improved inventory management while eliminating process variability.
Core Capabilities and Features
- DeltaV Batch: A modular and scalable batch execution solution supporting multi-product facilities with multi-stream recipes spanning many controllers.
- DeltaV Spectral PAT: Embedded Process Analytical Technology providing real-time multivariate analysis to enable fully automated manufacturing, improve speed-to-market, and support compliance with confidence.
- DeltaV Live HMI: The most advanced DeltaV human-machine interface, delivering increased operator productivity, simplified graphics configuration, and mobility.
- DeltaV Bridge: A hardware and software solution that simplifies integration between a DeltaV DCS and standalone equipment and devices.
- DeltaV Flex System: A packaged solution designed for modular system installations.
- PK Controller: Simplifies projects by enabling skid-builders to design and produce skids without the risks of integrating an additional controller into their system.
- Real-Time Modeling System and Scheduling: Increases capacity through process modeling and automation-driven, unsupervised finite scheduling for process optimization.
- Digital Twin: Reduces risk and cost from concept through operation while upskilling operator competencies using digital twin technologies.
- Equipment Diagnostics: An asset performance platform for managing and monitoring asset health.
- Syncade Starter Kits: Reduce risk and accelerate time to production with an out-of-the-box approach to MES implementation.
- Module Type Package (MTP): Enables easier integration of DCS and PLC-based systems.
- RX3i CPL410 Controller: Provides the foundation for Industrial Internet connectivity.
- Mimic Simulation Software: Achieves accurate, real-time simulation of plant behaviors.
- Process and Knowledge Management: Accelerates time to market for new therapies.
Data Access, Compliance, and Manufacturing Intelligence
- DeltaV technology enables greater access to data with context during manufacturing, supporting regulatory compliance and modular flexible facility architectures.
- Enhanced patch management keeps reporting current and supported across the plant.
- Streamlined combination of audit trails with overall batch reporting simplifies compliance documentation.
- Real-time product quality monitoring and data management capabilities are embedded throughout the platform.
- DeltaV Spectral PAT enables a simplified approach to real-time manufacturing with improved ROI and faster delivery of quality treatments to market.
Technology Transfer and Research and Development Support
- DeltaV technology supports flexible process development with seamless transfer from laboratory to manufacturing to commercial downstream operations.
- Common automation building blocks are leveraged at every stage to facilitate easy tech transfer.
- Integration and information management across R&D and manufacturing environments is simplified through consistent platform architecture.
OEM and Standardized Solution Implementation
- Emerson experts collaborate with OEMs and end users to deliver standardized DeltaV solutions that minimize extra development costs.
- Industry-leading technologies including Smart Commissioning, CHARMs, and the PK Controller allow OEMs to accommodate late adjustments to match unique end-user requirements.
- A dedicated DeltaV Life Sciences Program for OEMs supports faster and easier project changes.
Project Execution and Digital Transformation
- Project Certainty digitally transforms capital project delivery through agile project management strategies and collaborative engineering and planning practices.
- The global project execution approach accommodates late changes, optimizes equipment testing and commissioning, and provides a digital transformation roadmap.
- Solutions are designed to improve both capital and operating efficiencies, delivered reliably and quickly.
- IIoT innovations under an Industry 4.0 framework are applied to improve maintenance and reliability for life sciences operations.
Industry Segments Served
- Primary Manufacturing: Biologics drug substance and small molecule active pharmaceutical ingredients bulk production.
- Secondary Manufacturing: Biologics drug product and small molecule drug product manufacturing.
- Cell and Gene Therapy: Cell therapy and right-first-time manufacturing environments.
- Utilities: Utilities systems for life sciences facilities.
Emerson's DeltaV platform is supported by a global network of consultants and engineering expertise, with capabilities spanning design, implementation, startup, and ongoing optimization. The platform is further strengthened by Emerson's acquisition of Bio-G's dynamic optimization, simulation, and scheduling software, which helps digitalize life sciences operations and streamline technology transfer. Emerson's OEM program has also been extended specifically to the life sciences industry to reduce cost and time to bring therapies to market.
